---
layout: post
title: "港股歌礼制药涨超10%"
date: 2022-02-07 14:33:49 +0800
categories: hafuzixun
tags: 哈富资讯新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.01672" data-code="01672|116|5" data-code2="01672|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquotepic.eastmoney.com/GetPic.aspx?nid=116.01672&imageType=r&token=28dfeb41d35cc81d84b4664d7c23c49f" alt="R图 01672_0" data-code="R 01672|116|5" data-code2="R 01672|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" border="0" /></a></p><!-- EM_StockImg_End --><p>港股歌礼制药涨超10%，公司宣布口服PD-L1小分子抑制剂ASC61美国临床试验申请获批，用于治疗晚期实体瘤。 <br /></p><p class="em_media">（文章来源：哈富资讯）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202072268278657>

[返回哈富资讯新闻](//finews.withounder.com/category/hafuzixun.html)｜[返回首页](//finews.withounder.com/)